T1	Participants 236 291	general practitioners (GPs) for patients with diabetes.
T2	Participants 360 446	Cluster randomized controlled trial with 124 practices and 185 GPs in The Netherlands.
T3	Participants 1011 1094	1410 consultations with Type 2 diabetic patients at baseline and 1449 consultations
